Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Engineered Cpf1 for Efficient Genome Editing
2026-09-18
The reference protocol established a systematic framework for engineering Cpf1 (now commonly called Cas12a) crRNAs and mRNAs, rather than treating guide design and nuclease expression as fixed variables. Its findings show that optimized crRNA chemistry and modified Cpf1 mRNA can substantially improve editing, while T7E1 and targeted deep sequencing provide complementary measures of activity and specificity.
-
2X Taq PCR Master Mix for CAdV Genotyping
2026-09-18
A practical workflow for using 2X Taq PCR Master Mix to screen CAdV-2 variants, verify E3-region deletions, and prepare amplicons for downstream sequencing or TA cloning. The guide combines direct gel loading, assay controls, and troubleshooting strategies for reliable endpoint PCR.
-
Multiplexed ACE2 Libraries Map SARS-CoV-2 Receptor Shifts
2026-09-17
Shukla and colleagues developed a barcoded pseudotyped-virus assay that measures entry through many ACE2 sequence variants in parallel. The study shows that SARS-CoV-2 spike evolution produces modest changes in human ACE2 usage but substantially broader, variant-specific compatibility across animal ACE2 orthologs, offering a scalable framework for studying host-range evolution.
-
Mouse Neutrophil Cell Isolation Kit: Workflow
2026-09-17
Build fast, column-free neutrophil preparations for tumor immunology, nanovaccine testing, and functional assays. Negative selection minimizes direct labeling of target cells while supporting high-purity comparisons across bone marrow, blood, and spleen.
-
Multiomics Dissects Acute Liver Injury Therapies
2026-09-16
The reference study uses co-expression modules, regulatory-network analysis, transcriptomics, and proteomics to compare bifendate with muaddil sapra in CCl4-induced acute liver injury. Its main contribution is a systems-level interpretation showing that the treatments affect overlapping injury modules through distinct RNA, transcription-factor, and protein signatures.
-
Hyperthermia–Cisplatin Synergy in Cancer Cell Death
2026-09-16
The reference study identifies caspase-8 accumulation and activation as a mechanistic link between cisplatin, hyperthermia, apoptosis, and pyroptosis in cancer cells. Its combination of pharmacological, genetic, biochemical, and ultrastructural methods provides a useful framework for interpreting caspase activity measurement alongside broader cell-death phenotyping.
-
Cy3 NHS ester (non-sulfonated): Practical Guide
2026-09-15
Cy3 NHS ester (non-sulfonated) provides orange fluorescence for labeling accessible amino groups in proteins, peptides, oligonucleotides, and DNA-related biomolecules. It is appropriate when a DMSO or DMF co-solvent is acceptable, but not for strictly aqueous workflows or highly co-solvent-sensitive samples without compatibility testing.
-
Caspase-3 Fluorometric Assay Kit Workflow
2026-09-15
Turn DEVD-dependent fluorescence into a practical readout of executioner-caspase activation across apoptosis, ferroptosis–apoptosis crosstalk, and neurodegenerative disease models. This workflow combines rapid caspase activity measurement with orthogonal PARP1 and cell-death analyses to distinguish pathway activation from nonspecific loss of viability.
-
PBS Liposomes: Controls for Mechanistic Assays
2026-09-14
PBS Liposomes provide a matched carrier control for macrophage depletion experiments. This guide shows how K2722 improves causal interpretation and connects rigorous control design with mechanistic lessons from TRPM3 structural pharmacology.
-
Ibrutinib (PCI-32765): BTK Strategy Beyond B Cells
2026-09-14
A translational strategy for using Ibrutinib (PCI-32765) to interrogate B-cell receptor signaling, chronic lymphocytic leukemia biology, autoimmune disease models, and carefully bounded hypotheses emerging from ATRX-deficient glioma research.
-
Antibacterial Use and Resistance in a Psychiatric Hospital
2026-09-13
This retrospective study links antibacterial utilization, microbiological testing, and resistance patterns in a psychiatric hospital during the 2022 COVID-19 epidemic. Its main contribution is a stewardship-oriented view showing relatively restrained antibiotic use alongside substantial microbiological submission and clinically important resistance patterns, while also emphasizing that utilization trends cannot by themselves prove causation.
-
ML365: From TASK1 Pharmacology to POCD Translation
2026-09-12
ML365 connects selective TASK1 inhibition with membrane-potential biology and hippocampal NLRP3 signaling in a mouse model of postoperative cognitive impairment. This thought-leadership guide interprets the evidence, defines an assay-to-mechanism validation strategy, and identifies the limits that translational researchers should address before advancing the hypothesis.
-
Substrate Stiffness and LAMB1–FAK–MEK1/2 Dentinogenesis
2026-09-11
Bai et al. show that matrix stiffness directly regulates odontoblast-like cell behavior and mineralization through a LAMB1–FAK–MEK1/2 mechanotransduction axis. The study links cell–material mechanics with dentinogenic gene expression and provides a mechanistic framework for designing biomaterials for reparative dentin formation.
-
Cy3 NHS ester (non-sulfonated) Technical Guide
2026-09-11
Cy3 NHS ester (non-sulfonated) provides an orange fluorescent label for primary amino groups on proteins, peptides, and oligonucleotides when the workflow can tolerate an organic co-solvent. It is water-insoluble, so it is less suitable for delicate proteins that require fully aqueous labeling conditions; a sulfo-Cy3 NHS ester is a better alternative in that setting.
-
Annexin V-FITC/PI Apoptosis Assay Kit Guide
2026-09-10
Translate granulosa-cell biology into actionable apoptosis data with a rapid dual-parameter assay that separates viable, early apoptotic, and membrane-compromised populations. This workflow emphasizes calcium-dependent staining, flow cytometry controls, and interpretation alongside the AMH–SMAD4 findings reported in PCOS research.